Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Other Non Operating Income (2019 - 2025)

Biodesix (BDSX) has disclosed Other Non Operating Income for 7 consecutive years, with $46000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income fell 85.67% year-over-year to $46000.0, compared with a TTM value of $604000.0 through Dec 2025, up 6611.11%, and an annual FY2025 reading of $604000.0, up 727.4% over the prior year.
  • Other Non Operating Income was $46000.0 for Q4 2025 at Biodesix, down from $409000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $4.8 million in Q3 2023 and bottomed at -$7.1 million in Q4 2022.
  • Average Other Non Operating Income over 5 years is -$735736.8, with a median of $1000.0 recorded in 2021.
  • The sharpest move saw Other Non Operating Income plummeted 112600.0% in 2022, then surged 15950.0% in 2024.
  • Year by year, Other Non Operating Income stood at -$4.6 million in 2021, then crashed by 53.77% to -$7.1 million in 2022, then surged by 100.03% to $2000.0 in 2023, then soared by 15950.0% to $321000.0 in 2024, then plummeted by 85.67% to $46000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for BDSX at $46000.0 in Q4 2025, $409000.0 in Q3 2025, and $51000.0 in Q2 2025.